Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Director departure Quarterly results CC transcript Asset disposition Inv. presentation
|
HARVARD BIOSCIENCE INC (HBIO)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/14/2023 |
SC 13G
| Harvey Partners, LLC reports a 7% stake in HARVARD BIOSCIENCE, INC. |
12/21/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
07/08/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
06/21/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/14/2022 |
SC 13G
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. reports a 5.3% stake in Harvard Bioscience Inc. |
09/03/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/02/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
07/17/2019 |
SC 13G
| Potomac Capital Management, Inc. reports a 5.7% stake in Harvard Bioscience, Inc. |
02/07/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/09/2018 |
SC 13G
| DIMENSIONAL FUND ADVISORS LP reports a 5.1% stake in HARVARD BIOSCIENCE INC |
07/07/2017 |
SC 13G
| First Light Asset Management, LLC reports a 10.3% stake in Harvard Bioscience, Inc. |
02/14/2017 |
SC 13G
| First Light Asset Management, LLC reports a 8% stake in Harvard Bioscience, Inc. |
02/16/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
02/05/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
02/14/2012 |
SC 13G
| HARVARD BIOSCIENCE INC reports a 5% stake in HARVARD BIOSCIENCE INC |
02/09/2012 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
06/03/2010 |
SC 13G
| Central Square Management, LLC reports a 5.2% stake in HARVARD BIOSCIENCE, INC. |
04/13/2009 |
SC 13G
| Form SC 13G -- Statement of acquisition of beneficial ownership by individuals |
01/22/2009 |
SC 13G
| F&C Asset Management plc reports a 5.2% stake in Harvard Bioscience, Inc. |
|
|